Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Vernino

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Neurology|February 13, 2008
Combined immunomodulatory therapy in autoimmune autonomic ganglionopathyChristopher H Gibbons, Steven A Vernino, Roy Freeman
Journal of the Peripheral Nervous System : JPNS|May 3, 2012
Idiopathic neuropathy: new paradigms, new promiseMike A Singer, Steven A Vernino, Gil I Wolfe
Neurology|October 12, 2005
L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathyChristopher H Gibbons, Steven A Vernino, Horacio Kaufmann, et al.
Neurology and Therapy|February 7, 2022
Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons LearnedKyle M Blackburn, David A Denney, Steven C Hopkins, et al.
Archives of Neurology|May 19, 2004
Copper deficiency myelopathyNeeraj Kumar, Brian Crum, Ronald C Petersen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Neurology|February 13, 2008
Combined immunomodulatory therapy in autoimmune autonomic ganglionopathyChristopher H Gibbons, Steven A Vernino, Roy Freeman
Journal of the Peripheral Nervous System : JPNS|May 3, 2012
Idiopathic neuropathy: new paradigms, new promiseMike A Singer, Steven A Vernino, Gil I Wolfe
Neurology|October 12, 2005
L-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathyChristopher H Gibbons, Steven A Vernino, Horacio Kaufmann, et al.
Neurology and Therapy|February 7, 2022
Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons LearnedKyle M Blackburn, David A Denney, Steven C Hopkins, et al.
Archives of Neurology|May 19, 2004
Copper deficiency myelopathyNeeraj Kumar, Brian Crum, Ronald C Petersen, et al.
Pageof 1